Fidabio Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series B
  • (Upcoming)

  • Investors
  • 3

Fidabio General Information

Description

Operator of a biophysics platform intended to ease the process of quantitative characterization and quantification of proteins and nanoparticles. The company's platform utilizes a new proprietary technology that allows early detection of immune responses, makes affinity assessment significantly faster than existing methods, and requires small sample volumes, enabling researchers and drug developers to study complex interactions and quantifications using simple workflows with direct measurement in purified and unpurified matrices, labeled and label-free.

Contact Information

Website
www.fidabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Generatorvej 6A
  • 2860 Soborg
  • Denmark
+45 53
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • Generatorvej 6A
  • 2860 Soborg
  • Denmark
+45 53

Fidabio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fidabio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) Upcoming Generating Revenue
8. Later Stage VC (Series A) 16-Dec-2025 Completed Generating Revenue
7. Later Stage VC 24-Oct-2024 Completed Generating Revenue
6. Later Stage VC 16-May-2023 Completed Generating Revenue
5. Later Stage VC (Series 1) 30-May-2022 Completed Generating Revenue
4. Later Stage VC 31-Dec-2021 Completed Generating Revenue
3. Later Stage VC 31-Dec-2020 Completed Generating Revenue
2. Grant 01-Dec-2019 $2.2M $667K Completed Generating Revenue
1. Later Stage VC 26-Jun-2019 $667K $667K Completed Generating Revenue
To view Fidabio’s complete valuation and funding history, request access »

Fidabio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Preference
Preference
Preference
Preference
Preference 30,768 $26.55 $26.55 1x $26.55 9.22%
Series 1 36,818 $18.7 $18.7 1x $18.7 11.04%
To view Fidabio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Fidabio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biophysics platform intended to ease the process of quantitative characterization and quantification of pr
Discovery Tools (Healthcare)
Soborg, Denmark
29 As of 2025

Munich, Germany
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fidabio Competitors (4)

One of Fidabio’s 4 competitors is NanoTemper Technologies, a Corporation company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NanoTemper Technologies Corporation Munich, Germany
Refeyn Venture Capital-Backed Oxford, United Kingdom
Fluidic Analytics Venture Capital-Backed Royston, United Kingdom
Cytiva Formerly Accelerator/Incubator backed Marlborough, MA
To view Fidabio’s complete competitors history, request access »

Fidabio Patents

Fidabio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025256713-A1 A spectral related intensity change (sric) method, a binding related intensity change (bric) method for determining a characteristic parameter of particles and a folding related intensity change (fric) method Pending 11-Jun-2024
WO-2025201612-A1 A sensor system for fluorescence detection Pending 27-Mar-2024
EP-4792117-A1 A method of determining a binding parameter between a first particle and a second particle Pending 13-Oct-2023
WO-2025077984-A1 A method of determining a binding parameter between a first particle and a second particle Inactive 13-Oct-2023
EP-4777814-A1 A method of determining a parameter of a sample of a substance comprising particles in a liquid Pending 13-Sep-2023 G01N15/0205
To view Fidabio’s complete patent history, request access »

Fidabio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fidabio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fåhraeus Startup and Growth Venture Capital Minority
Horizon 2020 Government
Denmark's Export and Investment Fund Venture Capital Minority
To view Fidabio’s complete investors history, request access »

Fidabio FAQs

  • When was Fidabio founded?

    Fidabio was founded in 2012.

  • Where is Fidabio headquartered?

    Fidabio is headquartered in Soborg, Denmark.

  • What is the size of Fidabio?

    Fidabio has 29 total employees.

  • What industry is Fidabio in?

    Fidabio’s primary industry is Discovery Tools (Healthcare).

  • Is Fidabio a private or public company?

    Fidabio is a Private company.

  • What is Fidabio’s current revenue?

    The current revenue for Fidabio is .

  • How much funding has Fidabio raised over time?

    Fidabio has raised $16.4M.

  • Who are Fidabio’s investors?

    Fåhraeus Startup and Growth, Horizon 2020, and Denmark's Export and Investment Fund have invested in Fidabio.

  • Who are Fidabio’s competitors?

    NanoTemper Technologies, Refeyn, Fluidic Analytics, and Cytiva are competitors of Fidabio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process